SCHEMBL4070795

SCHEMBL4070795

OC[C@H]1OC2O[C@@H]2[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4070797 1.00
SCHEMBL4911680 0.92 ALDH1A1 (0.67)
SCHEMBL1193222 0.92 ALDH1A1 (0.67)
SCHEMBL28471882 0.92 ALDH1A1 (0.67)
SCHEMBL18736267 0.92 ALDH1A1 (0.67)
SCHEMBL4911675 0.92 ALDH1A1 (0.67)
SCHEMBL16016300 0.92 ALDH1A1 (0.67)
SCHEMBL6450045 0.92 ALDH1A1 (0.67)
SCHEMBL890314 0.92 ALDH1A1 (0.67)
SCHEMBL6266510 0.92 ALDH1A1 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594882-B1 PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES MERCK & CO INC (US) 2009-07-01 EP disclosed
US-7339054-B2 Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates MERCK & CO., INC. (US) 2008-03-04 US disclosed
US-7339054-B2 Process for preparing branched ribonucleosides from 1,2-anhydroribofuranose intermediates MERCK & CO., INC. (US) 2008-03-04 US disclosed
US-20070037771-A1 Reacting 2-Anhydro-3,5-di-O-(p-toluoyl)-2-C-methyl- alpha -D-ribofuranose with nucleophile such as cytosine, uracil, thymine, hypoxanthine, adenine, guanine, 7-deazaguanine, 7-deazaadenine, 7-deaza-2,6-diaminopurine, and 7-deazahypoxanthine, removing hydroxyl protecting groups MERCK SHARP & DOHME CORP. 2007-02-15 US disclosed
US-20070037771-A1 Reacting 2-Anhydro-3,5-di-O-(p-toluoyl)-2-C-methyl- alpha -D-ribofuranose with nucleophile such as cytosine, uracil, thymine, hypoxanthine, adenine, guanine, 7-deazaguanine, 7-deazaadenine, 7-deaza-2,6-diaminopurine, and 7-deazahypoxanthine, removing hydroxyl protecting groups MERCK SHARP & DOHME CORP. 2007-02-15 US disclosed
EP-1594882-A1 PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES Merck & Co., Inc. (US) 2005-11-16 EP disclosed
WO-2004072090-A1 PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES MERCK & CO. INC. (US) 2004-08-26 WO disclosed